Rapt Therapeutics, Inc. (RAPT)
35.32
+0.38
(+1.09%)
USD |
NASDAQ |
Dec 09, 16:00
35.28
-0.04
(-0.11%)
After-Hours: 20:00
Rapt Therapeutics EPS Diluted (Quarterly): -0.652 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.9041 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.58M |
| Total Expenses (Quarterly) | 17.58M |
| Enterprise Value | 429.37M |
| Earnings Yield | -29.76% |
| Normalized Earnings Yield | -29.76 |